Aijun Liao, M.D., Ph.D.
2018-Present, visiting scholar, City of Hope, Duarte, CA
2005, Ph.D., Pathology and Pathophysiology, China Medical University, China
1999, M.S., Internal Medicine, China Medical University, China
1994, B.S., Pediatrics , China Medical University, China
2018-Present, Visiting Scholar, Department of Systems Biology, Beckman Research Institute of City of Hope, City of Hope, Duarte, CA
2012-2018, Professor, Department of Hematology, Shengjing Hospital of China Medical University, China
2009-2010, Visiting Scholar, Penn State Cancer Institute, Hershey, PA
2006-2012, Associate Professor, Department of Hematology, Shengjing Hospital of China Medical University, China
2002-2006, Attending Physician, Department of Hematology, Shengjing Hospital of China Medical University, China
1994-2002, Resident, Department of Hematology, Shengjing Hospital of China Medical University, China
Hematology Association of Chinese Medical Doctor Association (Multiple Myeloma Group)
Hematology Association of Chinese Geriatrics Society (Multiple Myeloma Group)
Hematology Association of Chinese Medical Association (9th and 10th Chapter of the Infectious Diseases Group)
Chinese Society of Immunology (4th Chapter)
Chinese Academy of Research-Oriented Hospital Committee on Precise Treatment of Hematopathy
Liaoning Medical Association (Hematology)
Liaoning Institute of Hematology and Immunology (Deputy Director)
China Cancer Association, Liaoning Branch (Lymphoma Specialized Committee)
- Yang R, Huang J, Ma H, Li S, Gao X, Liu Y, Shen J, Liao A#.Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma? Leuk Lymphoma. 2019 Jan 10:1-7.
- Fu D, Li Y, Li J, Shi X, Yang R, Zhong Y, Wang H, Liao A#. The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells. Mol Cell Biochem. 2017 Jan;424(1-2):185-193.
- Liu H, Wang H, Wu B, Yao K, Liao A, Miao M, Li Y, Yang W. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma. Clin Exp Pharmacol Physiol. 2017 Oct;44(10):1032-1041.
- Wang H, Wang X, Liao A, Liu Z. Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway. Mol Cell Biochem. 2017 Sep;433(1-2):141-148.
- Wang H, Wang X, Xin N, Qi L, Liao A, Yang W, Liu Z, Zhao C. Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal. Mol Cell Biochem. 2017 Oct;434(1-2):25-32.
- Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K, Zhang R, Wang H, Yang W, Liu Z. Autophagy induced by FTY720 promotes apoptosis in U266 cells. Eur J Pharm Sci. 2012 Apr 11;45(5):600-5.
- Saadatpour A, Wang RS, Liao A, Liu X, Loughran TP, Albert I, Albert R.Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia. PLoS Comput Biol. 2011 Nov;7(11):e1002267.
- Liao A, Broeg K, Fox T, Tan SF, Watters R, Shah MV, Zhang LQ, Li Y, Ryland L, Yang J, Aliaga C, Dewey A, Rogers A, Loughran K, Hirsch L, Jarbadan NR, Baab KT, Liao J, Wang HG, Kester M, Desai D, Amin S, Loughran Jr. TP, Liu X. Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia. Blood. 2011 Sep 8;118(10):2793-800.
- Liu X, Ryland L, Yang J, Liao A, Aliaga C, Watts R, Tan SF, Kaiser J, Shanmugavelandy SS, Rogers A, Loughran K, Petersen B, Yuen J, Meng F, Baab KT, Jarbadan NR, Broeg K, Zhang R, Liao J, Sayers TJ, Kester M, Loughran Jr. TP. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood. 2010 Nov 18;116(20):4192-201.